Dolasetron: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dolasetron. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Pain | 0% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
ANZEMET Tablets are indicated for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, including initial and repeat courses in adults and children 2 years and older.
Source: FDA labeling via NIH DailyMed (set 201b0eb8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.